Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis

Howard, 1995, Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation, Methods Enzymol., 248, 388, 10.1016/0076-6879(95)48025-0 Weber, 2012, Ectodomain shedding and ADAMs in development, Development, 139, 3693, 10.1242/dev.076398 Edwards, 2008, The ADAM metalloproteinases, Mol. Asp. Med., 29, 258, 10.1016/j.mam.2008.08.001 Endres, 2012, Regulation of alpha-secretase ADAM10 expression and activity, Exp. Brain Res., 217, 343, 10.1007/s00221-011-2885-7 Reiss, 2009, The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions, Semin. Cell Dev. Biol., 20, 126, 10.1016/j.semcdb.2008.11.002 Jones, 2016, ADAM proteases and gastrointestinal function, Annu. Rev. Physiol., 78, 243, 10.1146/annurev-physiol-021014-071720 Scheller, 2011, ADAM17: a molecular switch to control inflammation and tissue regeneration, Trends Immunol., 32, 380, 10.1016/j.it.2011.05.005 Khokha, 2013, Metalloproteinases and their natural inhibitors in inflammation and immunity, Nat. Rev. Immunol., 13, 649, 10.1038/nri3499 Philpott, 2014, Lineage selection and plasticity in the intestinal crypt, Curr. Opin. Cell Biol., 31, 39, 10.1016/j.ceb.2014.07.002 Tetteh, 2015, Plasticity within stem cell hierarchies in mammalian epithelia, Trends Cell Biol., 25, 100, 10.1016/j.tcb.2014.09.003 Beumer, 2016, Regulation and plasticity of intestinal stem cells during homeostasis and regeneration, Development, 143, 3639, 10.1242/dev.133132 Demitrack, 2016, Notch regulation of gastrointestinal stem cells, J. Physiol., 594, 4791, 10.1113/JP271667 Gerbe, 2016, Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites, Nature, 529, 226, 10.1038/nature16527 Howitt, 2016, Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut, Science, 351, 1329, 10.1126/science.aaf1648 von Moltke, 2016, Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit, Nature, 529, 221, 10.1038/nature16161 Spence, 2011, Vertebrate intestinal endoderm development, Dev. Dyn., 240, 501, 10.1002/dvdy.22540 Zorn, 2009, Vertebrate endoderm development and organ formation, Annu. Rev. Cell Dev. Biol., 25, 221, 10.1146/annurev.cellbio.042308.113344 Grosse, 2011, Cell dynamics in fetal intestinal epithelium: implications for intestinal growth and morphogenesis, Development, 138, 4423, 10.1242/dev.065789 Walton, 2012, Hedgehog-responsive mesenchymal clusters direct patterning and emergence of intestinal villi, Proc. Natl. Acad. Sci. U. S. A., 109, 15817, 10.1073/pnas.1205669109 Barker, 2014, Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration, Nat. Rev. Mol. Cell Biol., 15, 19, 10.1038/nrm3721 Sancho, 2015, Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease, EMBO Rep., 16, 571, 10.15252/embr.201540188 Barker, 2007, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 449, 1003, 10.1038/nature06196 de Lau, 2011, Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling, Nature, 476, 293, 10.1038/nature10337 Ruffner, 2012, R-Spondin potentiates Wnt/beta-catenin signaling through orphan receptors LGR4 and LGR5, PLoS One, 7, 10.1371/journal.pone.0040976 Fre, 2005, Notch signals control the fate of immature progenitor cells in the intestine, Nature, 435, 964, 10.1038/nature03589 Vooijs, 2007, Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE, Development, 134, 535, 10.1242/dev.02733 Kopinke, 2011, Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas, Development, 138, 431, 10.1242/dev.053843 Carulli, 2015, Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration, Dev. Biol., 10.1016/j.ydbio.2015.03.012 Riccio, 2008, Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2, EMBO Rep., 9, 377, 10.1038/embor.2008.7 Tian, 2015, Opposing activities of notch and wnt signaling regulate intestinal stem cells and gut homeostasis, Cell Rep., 11, 33, 10.1016/j.celrep.2015.03.007 VanDussen, 2012, Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells, Development, 139, 488, 10.1242/dev.070763 Fre, 2009, Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine, Proc. Natl. Acad. Sci. U. S. A., 106, 6309, 10.1073/pnas.0900427106 Pellegrinet, 2011, Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells, Gastroenterology, 140, 1230, 10.1053/j.gastro.2011.01.005 Farin, 2012, Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells, Gastroenterology, 143, 1518, 10.1053/j.gastro.2012.08.031 Kim, 2012, Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells, Proc. Natl. Acad. Sci. U. S. A., 109, 3932, 10.1073/pnas.1113890109 van Es, 2005, Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease, Trends Mol. Med., 11, 496, 10.1016/j.molmed.2005.09.008 van Es, 2005, Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature, 435, 959, 10.1038/nature03659 San Roman, 2014, Wnt secretion from epithelial cells and subepithelial myofibroblasts is not required in the mouse intestinal stem cell niche in vivo, Stem Cell Rep., 2, 127, 10.1016/j.stemcr.2013.12.012 Sangiorgi, 2008, Bmi1 is expressed in vivo in intestinal stem cells, Nat. Genet., 40, 915, 10.1038/ng.165 Montgomery, 2011, Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells, Proc. Natl. Acad. Sci. U. S. A., 108, 179, 10.1073/pnas.1013004108 Takeda, 2011, Interconversion between intestinal stem cell populations in distinct niches, Science, 334, 1420, 10.1126/science.1213214 Powell, 2012, The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor, Cell, 149, 146, 10.1016/j.cell.2012.02.042 Wong, 2012, Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling, Nat. Cell Biol., 14, 401, 10.1038/ncb2464 Munoz, 2012, The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers, EMBO J., 31, 3079, 10.1038/emboj.2012.166 Buczacki, 2013, Intestinal label-retaining cells are secretory precursors expressing Lgr5, Nature, 495, 65, 10.1038/nature11965 Li, 2016, Mouse label-retaining cells are molecularly and functionally distinct from reserve intestinal stem cells, Gastroenterology, 151, 298, 10.1053/j.gastro.2016.04.049 van Es, 2012, Dll1+ secretory progenitor cells revert to stem cells upon crypt damage, Nat. Cell Biol., 14, 1099, 10.1038/ncb2581 Roche, 2015, SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine, Gastroenterology, 149, 1553, 10.1053/j.gastro.2015.07.004 Schonhoff, 2004, Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types, Dev. Biol., 270, 443, 10.1016/j.ydbio.2004.03.013 Tetteh, 2016, Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters, Cell Stem Cell, 18, 203, 10.1016/j.stem.2016.01.001 Asfaha, 2015, Krt19(+)/Lgr5(−) cells are radioresistant cancer-initiating stem cells in the colon and intestine, Cell Stem Cell, 16, 627, 10.1016/j.stem.2015.04.013 Westphalen, 2014, Long-lived intestinal tuft cells serve as colon cancer-initiating cells, J. Clin. Invest., 124, 1283, 10.1172/JCI73434 Chandrakesan, 2015, Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal, Oncotarget, 6, 30876, 10.18632/oncotarget.5129 Gross, 2015, Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potential, Am. J. Physiol. Gastrointest. Liver Physiol., 309, G975, 10.1152/ajpgi.00244.2015 Kim, 2014, Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity, Nature, 506, 511, 10.1038/nature12903 Tsai, 2014, ADAM10 regulates Notch function in intestinal stem cells of mice, Gastroenterology, 147, 822, 10.1053/j.gastro.2014.07.003 Wild-Bode, 2006, A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration, J. Biol. Chem., 281, 23824, 10.1074/jbc.M601542200 Feng, 2012, Intestinal epithelial cell responses to total parenteral nutrition (TPN) are under complex regulation by ADAM17, Gastroenterology, 142, S-61 Gibb, 2010, ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo, J. Exp. Med., 207, 623, 10.1084/jem.20091990 Groot, 2013, Epidermal ADAM17 is dispensable for notch activation, J. Invest. Dermatol., 133, 2286, 10.1038/jid.2013.162 Hartmann, 2002, The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts, Hum. Mol. Genet., 11, 2615, 10.1093/hmg/11.21.2615 Jorissen, 2010, The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex, J. Neurosci., 30, 4833, 10.1523/JNEUROSCI.5221-09.2010 Tian, 2008, ADAM10 is essential for proteolytic activation of Notch during thymocyte development, Int. Immunol., 20, 1181, 10.1093/intimm/dxn076 Tsai, 2010, Role of ADAM10 signaling in cell prolieration and cell fate specification is conserved between the developing and adult intestine, Gastroenterology, 138, S-566, 10.1016/S0016-5085(10)62606-6 Weber, 2011, The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling, Development, 138, 495, 10.1242/dev.055210 Weber, 2013, Regulation of adult hematopoiesis by the a disintegrin and metalloproteinase 10 (ADAM10), Biochem. Biophys. Res. Commun., 442, 234, 10.1016/j.bbrc.2013.11.020 Groot, 2014, Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins, Mol. Cell. Biol., 34, 2822, 10.1128/MCB.00206-14 van Tetering, 2009, Metalloprotease ADAM10 is required for Notch1 site 2 cleavage, J. Biol. Chem., 284, 31018, 10.1074/jbc.M109.006775 Habets, 2015, Human NOTCH2 is resistant to ligand-independent activation by metalloprotease Adam17, J. Biol. Chem., 290, 14705, 10.1074/jbc.M115.643676 Aster, 2014, In brief: Notch signalling in health and disease, J. Pathol., 232, 1, 10.1002/path.4291 Feng, 2015, Loss of ADAM17-mediated tumor necrosis factor alpha signaling in intestinal cells attenuates mucosal atrophy in a mouse model of parenteral nutrition, Mol. Cell. Biol., 35, 3604, 10.1128/MCB.00143-15 D'Souza, 2014, Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-beta, Sci. Signal., 7, rs5 Dyczynska, 2007, Proteolytic processing of delta-like 1 by ADAM proteases, J. Biol. Chem., 282, 436, 10.1074/jbc.M605451200 LaVoie, 2003, The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments, J. Biol. Chem., 278, 34427, 10.1074/jbc.M302659200 Lu, 2013, Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1, Cancer Cell, 23, 171, 10.1016/j.ccr.2012.12.021 Zolkiewska, 2008, ADAM proteases: ligand processing and modulation of the Notch pathway, Cell. Mol. Life Sci., 65, 2056, 10.1007/s00018-008-7586-4 Parr-Sturgess, 2010, Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event, Biochem. Jj., 432, 283, 10.1042/BJ20100321 Wang, 2016, A disintegrin and metalloproteinase domain 17 regulates colorectal cancer stem cells and chemosensitivity via Notch1 signaling, Stem Cells Transl. Med., 5, 331, 10.5966/sctm.2015-0168 Ikeuchi, 2003, The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent “gamma-secretase” cleavage, J. Biol. Chem., 278, 7751, 10.1074/jbc.C200711200 Tu, 2005, Notch signaling is an important regulator of type 2 immunity, J. Exp. Med., 202, 1037, 10.1084/jem.20050923 Murtaugh, 2003, Notch signaling controls multiple steps of pancreatic differentiation, Proc. Natl. Acad. Sci. U. S. A., 100, 14920, 10.1073/pnas.2436557100 Rustagi, 2015, ADAM10-mediated Notch signaling is essential for maintenance of BMI1+ intestinal stem cells, Gastroenterology, 148, S106, 10.1016/S0016-5085(15)30365-6 Fre, 2011, Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice, PLoS One, 6, 10.1371/journal.pone.0025785 Tian, 2011, A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable, Nature, 478, 255, 10.1038/nature10408 Bhattacharyya, 2014, Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases, Physiol. Rev., 94, 329, 10.1152/physrev.00040.2012 Coant, 2010, NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon, Mol. Cell. Biol., 30, 2636, 10.1128/MCB.01194-09 Bass, 2010, ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?, Biochem. J., 428, e3, 10.1042/BJ20100568 Sanderson, 2005, ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx, J. Biol. Chem., 280, 1826, 10.1074/jbc.M408804200 Qu, 2014, Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt epithelial stem cells following radiation injury, Am. J. Physiol. Gastrointest. Liver Physiol., 306, G404, 10.1152/ajpgi.00088.2013 Tran, 2013, Blockade of individual Notch ligands and receptors controls graft-versus-host disease, J. Clin. Invest., 123, 1590, 10.1172/JCI65477 Jones, 2017, Reversion of DEFA4Cre-expressing Paneth cells to a stem cell state in response to Notch activation aor intestinal injury, Gastroenterology, 152, S217, 10.1016/S0016-5085(17)34363-9 Zheng, 2011, Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis, Inflamm. Bowel Dis., 17, 2251, 10.1002/ibd.21611 Gersemann, 2011, From intestinal stem cells to inflammatory bowel diseases, World J. Gastroenterol., 17, 3198 Radtke, 2013, Regulation of innate and adaptive immunity by Notch, Nat. Rev. Immunol., 13, 427, 10.1038/nri3445 Xu, 2012, Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization, Nat. Immunol., 13, 642, 10.1038/ni.2304 Tsai, 2013, Myeloid-specific deletion of ADAM10 dramatically increases susceptibility to DSS-induced colitis, Gastroenterology, 144, S-308, 10.1016/S0016-5085(13)61109-9 Wright, 1990, Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells, Nature, 343, 82, 10.1038/343082a0 Maretzky, 2005, ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation, Proc. Natl. Acad. Sci. U. S. A., 102, 9182, 10.1073/pnas.0500918102 Maretzky, 2008, ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis, J. Invest. Dermatol., 128, 1737, 10.1038/sj.jid.5701242 Batlle, 2002, Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB, Cell, 111, 251, 10.1016/S0092-8674(02)01015-2 Solanas, 2011, Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling, Nat. Cell Biol., 13, 1100, 10.1038/ncb2298 Janes, 2005, Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans, Cell, 123, 291, 10.1016/j.cell.2005.08.014 Duffy, 2009, Role of ADAMs in cancer formation and progression, Clin. Ccancer Res., 15, 1140, 10.1158/1078-0432.CCR-08-1585 Murphy, 2008, The ADAMs: signalling scissors in the tumour microenvironment, Nat. Rev. Cancer, 8, 929, 10.1038/nrc2459 Miller, 2016, Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance, Cancer Discov., 6, 382, 10.1158/2159-8290.CD-15-0933 Miller, 2017, molecular pathways: receptor ectodomain shedding in treatment, resistance, and monitoring of cancer, Clin. Ccancer Res., 23, 623, 10.1158/1078-0432.CCR-16-0869 Mullooly, 2016, The ADAMs family of proteases as targets for the treatment of cancer, Cancer Biol. Ther., 17, 870, 10.1080/15384047.2016.1177684 Weeber, 2015, Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases, Proc. Natl. Acad. Sci. U. S. A., 112, 13308, 10.1073/pnas.1516689112 Noah, 2013, SPDEF functions as a colorectal tumor suppressor by inhibiting beta-catenin activity, Gastroenterology, 144, 1012, 10.1053/j.gastro.2013.01.043 Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 457, 608, 10.1038/nature07602 Tsai, 2013, Cell-autonomous ADAM10 signaling is required for adenoma initiation after APC mutation, Gastroenterology, 144, S-51, 10.1016/S0016-5085(13)60182-1 Lo, 2017, SPDEF induces quiescence of colorectal cancer cells by changing the transcriptional targets of beta-catenin, Gastroenterology, 10.1053/j.gastro.2017.03.048 Aragaki, 2008, Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer, Biochem. Biophys. Res. Commun., 368, 923, 10.1016/j.bbrc.2008.02.011 Bossuyt, 2009, Atonal homolog 1 is a tumor suppressor gene, PLoS Biol., 7, 10.1371/journal.pbio.1000039 Sikandar, 2010, NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer, Cancer Res., 70, 1469, 10.1158/0008-5472.CAN-09-2557 Tsuchiya, 2007, Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer, Gastroenterology, 132, 208, 10.1053/j.gastro.2006.10.031 Peignon, 2011, Complex interplay between beta-catenin signalling and Notch effectors in intestinal tumorigenesis, Gut, 60, 166, 10.1136/gut.2009.204719 Mustafi, 2017, ADAM17 is a tumor promoter and therapeutic target in Western diet-associated colon cancer, Clin. Ccancer Res., 23, 549, 10.1158/1078-0432.CCR-15-3140 Chanrion, 2014, Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut, Nat. Commun., 5, 5005, 10.1038/ncomms6005 Sonoshita, 2015, Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO, Cancer Discov., 5, 198, 10.1158/2159-8290.CD-14-0595 Barker, 2010, Lineage tracing in the intestinal epithelium, Curr Protoc Stem Cell Biol, 10.1002/9780470151808.sc05a04s13 Al-Nedawi, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat. Cell Biol., 10, 619, 10.1038/ncb1725 Yang, 2011, The roles of tumor-derived exosomes in cancer pathogenesis, Clin. Dev. Immunol., 2011, 842849, 10.1155/2011/842849 Shimoda, 2016, Tumor suppression by stromal TIMPs, Mol. Cell. Oncol., 3 Shimoda, 2014, Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state, Nat. Cell Biol., 16, 889, 10.1038/ncb3021 Fiske, 2009, ERBBs in the gastrointestinal tract: recent progress and new perspectives, Exp. Cell Res., 315, 583, 10.1016/j.yexcr.2008.10.043 Leto, 2015, Sustained inhibition of HER3 and EGFR is necessary to induce regression of HER2-amplified gastrointestinal carcinomas, Clini. Cancer Res., 21, 5519, 10.1158/1078-0432.CCR-14-3066 Parikh, 2017, Prolonged response to HER2-directed therapy in a patient with HER2-amplified, rapidly progressive metastatic colorectal cancer, J. Natl. Compr. Canc. Netw., 15, 3, 10.6004/jnccn.2017.0002 Sartore-Bianchi, 2016, Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial, Lancet. Oncol., 17, 738, 10.1016/S1470-2045(16)00150-9 Ebbing, 2016, ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3, Oncotarget, 7, 10243, 10.18632/oncotarget.7200 Feldinger, 2014, ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer, Oncotarget, 5, 6633, 10.18632/oncotarget.1955 Xia, 2013, An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models, Breast Cancer Res., 15, R85, 10.1186/bcr3480 Fridman, 2007, Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer, Clini. Cancer Res., 13, 1892, 10.1158/1078-0432.CCR-06-2116 Liu, 2006, Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells, Cancer Biol. Ther., 5, 657, 10.4161/cbt.5.6.2708 Zhou, 2005, ADAM proteases, ErbB pathways and cancer, Expert Opin. Investig. Drugs, 14, 591, 10.1517/13543784.14.6.591 Zhou, 2006, Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer, Cancer Cell, 10, 39, 10.1016/j.ccr.2006.05.024 Ardito, 2012, EGF receptor is required for KRAS-induced pancreatic tumorigenesis, Cancer Cell, 22, 304, 10.1016/j.ccr.2012.07.024 Chio, 2016, NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer, Cell, 166, 963, 10.1016/j.cell.2016.06.056 Waldner, 2014, Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development, Semin. Immunol., 26, 75, 10.1016/j.smim.2013.12.003 Lanaya, 2014, EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation, Nat. Cell Biol., 16, 972, 10.1038/ncb3031 Srivatsa, 2017, EGFR in tumor-associated myeloid cells promotes development of colorectal cancer in mice and associates with outcomes of patients, Gastroenterology, 10.1053/j.gastro.2017.03.053 Hardbower, 2017, EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis, Oncogene, 10.1038/onc.2017.23 Atreya, 2000, Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo, Nat. Med., 6, 583, 10.1038/75068 Becker, 2004, TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling, Immunity, 21, 491, 10.1016/j.immuni.2004.07.020 Matsumoto, 2010, Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model, J. Immunol., 184, 1543, 10.4049/jimmunol.0801217 Mitsuyama, 2006, STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice, Gut, 55, 1263, 10.1136/gut.2005.079343